Nuveen Asset Management, LLC Guardant Health, Inc. Transaction History

Nuveen Asset Management, LLC

$334 Billion
Q2 2024

A detailed history of Nuveen Asset Management, LLC transactions in Guardant Health, Inc. stock. As of the latest transaction made, Nuveen Asset Management, LLC holds 1,309,719 shares of GH stock, worth $30 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

1,309,719

Previous 817,509 60.21%

Holding current value

$30 Million

Previous $16.9 Million 124.28%

% of portfolio

0.01%

Previous 0.01%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 09, 2024	BUY	$16.07 - $31.84 $7.91 Million - $15.7 Million	492,210 Added 60.21%	1,309,719 $37.8 Million
Q1 2024 May 13, 2024	SELL	$17.13 - $26.91 $2.09 Million - $3.28 Million	-122,021 Reduced 12.99%	817,509 $16.9 Million
Q4 2023 Feb 14, 2024	BUY	$21.58 - $29.5 $3.93 Million - $5.37 Million	181,946 Added 24.02%	939,530 $25.4 Million
Q3 2023 Nov 14, 2023	SELL	$25.8 - $39.97 $664,685 - $1.03 Million	-25,763 Reduced 3.29%	757,584 $22.5 Million
Q2 2023 Aug 14, 2023	BUY	$20.94 - $38.01 $10.6 Million - $19.2 Million	504,070 Added 180.49%	783,347 $28 Million
Q1 2023 May 15, 2023	SELL	$22.92 - $33.76 $4.63 Million - $6.82 Million	-201,937 Reduced 41.96%	279,277 $6.55 Million
Q4 2022 Feb 14, 2023	SELL	$25.44 - $59.78 $1.15 Million - $2.7 Million	-45,170 Reduced 8.58%	481,214 $13.1 Million
Q3 2022 Nov 14, 2022	SELL	$43.66 - $61.0 $8.46 Million - $11.8 Million	-193,845 Reduced 26.91%	526,384 $28.3 Million
Q2 2022 Aug 15, 2022	SELL	$28.82 - $77.35 $28.9 Million - $77.6 Million	-1,003,327 Reduced 58.21%	720,229 $29.1 Million
Q1 2022 May 16, 2022	SELL	$48.25 - $100.49 $13.9 Million - $29 Million	-288,576 Reduced 14.34%	1,723,556 $99.4 Million
Q4 2021 Feb 14, 2022	SELL	$88.71 - $120.43 $23 Million - $31.2 Million	-259,271 Reduced 11.41%	2,012,132 $201 Million
Q3 2021 Nov 12, 2021	BUY	$98.77 - $132.17 $14 Million - $18.8 Million	142,210 Added 6.68%	2,271,403 $284 Million
Q2 2021 Aug 16, 2021	SELL	$109.77 - $165.68 $19.7 Million - $29.7 Million	-179,459 Reduced 7.77%	2,129,193 $264 Million
Q1 2021 May 17, 2021	BUY	$127.04 - $179.1 $30.8 Million - $43.5 Million	242,682 Added 11.75%	2,308,652 $352 Million
Q4 2020 Feb 16, 2021	SELL	$99.96 - $135.93 $81.4 Million - $111 Million	-813,974 Reduced 28.26%	2,065,970 $266 Million
Q3 2020 Nov 16, 2020	SELL	$80.32 - $111.8 $9.46 Million - $13.2 Million	-117,813 Reduced 3.93%	2,879,944 $322 Million
Q2 2020 Aug 14, 2020	BUY	$60.49 - $97.5 $86.3 Million - $139 Million	1,426,318 Added 90.77%	2,997,757 $243 Million
Q1 2020 May 14, 2020	BUY	$59.04 - $88.81 $9.14 Million - $13.7 Million	154,824 Added 10.93%	1,571,439 $109 Million
Q4 2019 Feb 14, 2020	SELL	$59.49 - $82.78 $250,036 - $347,924	-4,203 Reduced 0.3%	1,416,615 $111 Million
Q3 2019 Nov 14, 2019	BUY	$62.59 - $110.3 $11.7 Million - $20.6 Million	187,152 Added 15.17%	1,420,818 $90.7 Million
Q2 2019 Aug 15, 2019	BUY	$63.94 - $91.11 $78.9 Million - $112 Million	1,233,666 New	1,233,666 $107 Million

Others Institutions Holding GH

# of Institutions

331

Shares Held

116M

Call Options Held

680K

Put Options Held

1.66M

View Full List

About Guardant Health, Inc.

Ticker GH
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 102,220,000
Market Cap $2.34B
Description
Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...

More about GH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Nuveen Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nuveen Asset Management, LLC with notifications on news.

Account

Nuveen Asset Management, LLC Guardant Health, Inc. Transaction History